Max Robotics — Global Service Robot Directory + US Certification

About

David Jeller’s research centers on advancing the precision and consistency of stereotactic body radiotherapy (SBRT), particularly for pulmonary tumors. His most cited work, “Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose” (2021, 11 citations), tackles a critical challenge in radiation oncology: the substantial variability in dose prescription, normalization, and target coverage across institutions and SBRT platforms. Jeller demonstrated that prescribing to the mean internal target volume dose can harmonize treatment delivery, reducing discrepancies that previously compromised comparative studies and clinical outcomes. This contribution is vital for standardizing SBRT protocols, enabling more reliable multi-institutional trials and improving treatment reproducibility. His work has been recognized for its practical impact on clinical practice, offering a straightforward solution to a long-standing problem in pulmonary radiotherapy. With growing citations reflecting its relevance, Jeller’s research continues to influence how radiation oncologists approach dose prescription, making SBRT safer and more consistent for lung cancer patients worldwide.